Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × HIV Infections × X-Rays × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 6 Rhabdoid Tumor 6 Glioma 6 Wilms Tumor 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Neuroblastoma 5 Medulloblastoma 5 Lymphoma, Non-Hodgkin 5 Histiocytosis, Langerhans-Cell 5 Hepatoblastoma 5 Ependymoma 5 Rhabdomyosarcoma 4 Osteosarcoma 4 Multiple Myeloma 4 Central Nervous System Neoplasms 4 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Lymphoma 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Sarcoma, Ewing 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Neoplasm Metastasis 2 Malignant Solid Neoplasm 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2

Interventions

Etoposide 3 Peripheral Blood Stem Cell Transplantation 2 Cyclophosphamide 2 Carmustine 2 liposomal doxorubicin 1 carmustine, poliferprosan 20 drug combination 1 cabozantinib 1 Zidovudine 1 X-Rays 1 Vincristine 1 Valganciclovir 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Prednisone 1 Nivolumab 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Interferon-alpha 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Doxorubicin 1 Cytarabine 1 Colposcopy 1 Bortezomib 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡